TFPI Biosimilar Antibody
TFPI Biosimilar Antibody
Product Specifications
Product Name Alternative
Alhemo research-grade biosimilar; ANTI-TFPI research-grade biosimilar; Anti-TFPI monoclonal antibody research-grade biosimilar; Concizumab research-grade biosimilar; Concizumab (genetical recombination) (JAN) research-grade biosimilar; Concizumab (USAN) research-grade biosimilar; MAB-2021 research-grade biosimilar; MABTFPI2021 research-grade biosimilar; NN-7415 research-grade biosimilar; NNC-0172-0000-2021 research-grade biosimilar; NNC-0172-2021 research-grade biosimilar; NNC-172-2021 research-grade biosimilar ; TFPI antibody; LACI antibody; TFPI1 antibody; Tissue factor pathway inhibitor antibody; TFPI antibody; Extrinsic pathway inhibitor antibody; EPI antibody; Lipoprotein-associated coagulation inhibitor antibody; LACI antibody
UniProt
P10646
Reactivity
Human
Immunogen
Recombinant Human TFPI protein
Target
TFPI
Clonality
Monoclonal
Conjugation
Unconjugated
Purity
> 95% tested by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Preservative
0.01M PBS, pH 7.4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
